Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1998-6-11
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0031-6970
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
91-3
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9591937-Absorption,
pubmed-meshheading:9591937-Adult,
pubmed-meshheading:9591937-Aged,
pubmed-meshheading:9591937-Aged, 80 and over,
pubmed-meshheading:9591937-Colitis, Ulcerative,
pubmed-meshheading:9591937-Female,
pubmed-meshheading:9591937-Humans,
pubmed-meshheading:9591937-Male,
pubmed-meshheading:9591937-Middle Aged,
pubmed-meshheading:9591937-Rifamycins
|
pubmed:year |
1998
|
pubmed:articleTitle |
Rifaximin systemic absorption in patients with ulcerative colitis.
|
pubmed:publicationType |
Letter,
Clinical Trial
|